Maintenance immunotherapy in advanced urothelial cancer
Advanced urothelial carcinoma usually responds to platinum-based chemotherapy (CT), although overall survival (OS) and progression-free survival are typically short. Immunotherapy is a promising treatment strategy, but the first-line benefits in platinum-eligible patients are limited, and its combin...
Bewaard in:
| Hoofdauteurs: | , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Permanyer
2022-07-01
|
| Reeks: | Gaceta Mexicana de Oncología |
| Onderwerpen: | |
| Online toegang: | https://www.gamo-smeo.com/frame_esp.php?id=323 |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|